Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
70
about 1.4 years
50–80
1 site in MA
What this study is about
Researchers are testing a device called tACS to see if it can help people with mild cognitive impairment, which may be related to Alzheimer's disease. The trial will involve using an EEG and questionnaires to monitor participants during trial visits. The goal is to assess how this closed-loop neuromodulation impacts natural gamma rhythms in patients with AD-MCI and their cognitive performance.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use tACS device
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Neurology